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Who does the polarizing?
T cells can 'polarize' into T1 and T2 effector cell types in response to
distinct cytokines. T cells and cells presenting antigen to the T cells
are themselves candidate sources of these polarizing cytokines.
As they develop, T cells can become 'polarized' and
restricted to producing either T1 or T2 patterns of
cytokines: interleukin (IL)-12 and interferon y on the
one hand (T1), and IL-4 on the other (T2). The T1 and
T2 T-cell subsets mediate largely non-overlapping
immune functions that are specialized to deal effectively
with different classes of pathogens. The factors that regu-
late the production of interferon y/IL-12 and IL-4 at the
start of an immune response, which in turn could effect
this specialization into subsets, are however largely
unclear. The hypothesis that pathogens interact with dif-
ferent types of cells that present antigen to T cells, and
that these different antigen-presenting cells make - or
induce the T cells to make - different cytokines at the
initiation of an immune response, is gaining ground.
T cells are able to synthesize and secrete different pat-
terns and quantities of cytokines, depending on their
stage of differentiation and on whether they have polar-
ized to produce restricted patterns. Naive T cells and
uncommitted, resting memory T cells produce princi-
pally IL-2 [1], which they use for their own growth.
When the resting T-cell population differentiates into
an 'effector' stage, such differentiation is reflected in the
capacity for production of very large amounts of a
broad range of potent, hormone-like cytokines upon
restimulation [1,2]. At this and later points in their
development, individual T cells and clones derived from
them can produce many (or all) of the cytokines charac-
teristic of various types of T cell in a so-called TO pat-
tern. The TO pattern includes IL-2, IL-3, IL-4, IL-5,
IL-6, IL-10, granulocyte-macrophage colony-stimulat-
ing factor (GM-CSF), interferon y, lymphotoxin (LT)
and tumor necrosis factor (x (TNFac). Alternatively, T
cells can be restricted to producing one of two predomi-
nant patterns of cytokines: the T1 pattern - including
interferon y, TNFo, LT plus IL-3, and GM-CSF with or
without IL-2 - or a T2 pattern, including IL-4, IL-5,
IL-6, IL-10 and IL-13 [3].
This dichotomy has profound functional implications,
because the T1 cytokines are those best suited to partici-
pation in a spectrum of immune responses targeted at the
destruction of cells infected with intracellular parasites
(including bacteria and viruses), whereas the T2 pattern
of cytokines is specialized to aid in the development of
antibody responses and other immune mechanisms that
are effective against extracellular pathogens [3]. Develop-
ment of an inappropriately polarized T-cell response can
lead to ineffective immunity and can be pathogenic [4].
Thus, the factors that promote reciprocal polarization,
and the way the immune system reacts to pathogens to
assure the most advantageous polarization, are critical.
T-cell subsets were originally described for helper T cells,
which bear the cell-surface marker CD4; these cells rec-
ognize and respond to antigenic peptides derived primar-
ily from exogenous proteins that have been processed for
presentation by class II molecules of the major histocom-
patibility complex (MHC). But recently it has become
clear that CD8-bearing cytotoxic T cells, which recog-
nize peptides derived from proteins synthesized in the
cytoplasm and presented by class I MHC molecules [5,6],
are also susceptible to polarization, as are the minor T-cell
subsets bearing the yb rather than oa type of T-cell
receptor [7]. Even the 'double-negative' (CD4-, CD8-)
population that we have studied recently can be driven to
secrete polarized cytokine patterns (L. Cauley and S.L.S,
unpublished observations). Thus, we refer to T1 and T2
subsets, rather than using the earlier nomenclature of Thl
and Th2, which refers only to CD4-bearing helper cells.
The fact that this dichotomy extends .across the different
Fig. 1. T-cell subsets are defined by cytokine pattern. T cells of
multiple lineages and at multiple stages in their differentiation
can be driven to become polarized into different T-cell subsets if
they have not been previously committed. These subsets, identi-
fied as TO (still multipotential), or the restricted Ti and T2 subsets
are defined by the patterns of cytokines the cells make upon re-
stimulation.
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lineages of T cells, as summarized in Figure 1, re-enforces
the fundamental significance of subset polarization.
It is clear from analyses both in vitro and in vivo that the
cytokines IL-12 and interferon y can direct T cells to
become polarized to the T1 pattern, and that IL-4 can
direct them to the T2 pattern [8-10]. This suggests that
once a T-cell population begins to become polarized,
it will produce the cytokines needed to reinforce that
polarization. Polarization will be further strengthened
because of the ability of these same cytokines to suppress
the opposing responses [8,10,11]. If a responding major-
ity T1 population produces interferon y, it will actively
suppress development of T2-polarized cells, and the
cytokines IL-4 and IL-10 released from T2 cells will sup-
press both the development of T1 polarized cells (IL-4)
and the secretion of Tl-type cytokines (IL-10). Thus,
once polarization in a particular local environment has
begun, it has a tendency to become pronounced. These
features are summarized in Figure 2.
Experiments in vivo support the concept that, although
other cytokines can play important roles, IL-12 and IL-4
are both sufficient and necessary for T1 and T2 polariza-
tion during the response to pathogens or to proteins
(reviewed in [10]). Thus, the other factors that lead to
polarized subsets in vivo, such as the dose [12] and kind
[13] of antigen, or the involvement of particular antigen-
presenting cells [9,14,151 and/or co-stimulatory pathways
[16], are most likely to have their effects primarily by
altering production of the polarizing cytokines. But
where does the initial polarizing cytokine come from,
and how is its presence linked to the type of pathogen?
These questions have remained unanswered, although sev-
eral findings point the way towards testable hypotheses.
Both IL-12 and interferon y are produced by macrophages
and natural killer (NK) cells [9,17]. Interferon y is also
Fig. 2. Cytokines determine T-cell polarization. The presence of
IL-12 and/or interferon y drives previously uncommitted T cells
to become polarized to produce T1 cytokines, while IL-4 drives
them to become polarized to secrete T2 cytokines. T1 cytokines,
particularly interferon y, suppress both the induction of T2
T cells and the functions of T2 cytokines, whereas T2 cytokines,
particularly IL-4 and IL-10, in turn suppress development of T1
T cells and the functions of T1 cytokines.
produced by T1 cells, but IL-12 does not seem to be a
T-cell product [17]. Production of interferon y and IL-12
by macrophages is induced by infection with intracellular
bacteria [9] and by the products of inflammatory reac-
tions accompanying such an infection. This provides evi-
dence for the first direct link from a pathogen to a
polarized response appropriate to that pathogen. The sit-
uation for viral infections is less clear-cut, although the
theory that viruses will induce NK activity and IL-
12/interferon y production is an attractive one. The idea
that an antigen-presenting cell making a cytokine can
direct T-cell differentiation is particularly compelling,
because the T cell binds directly to the potential antigen-
presenting cells during recognition of antigen, allowing
small quantities of cytokine secreted by the antigen-
presenting cell to be directed to the T cell.
Potential sources of IL-4 are not as clear. None of the
traditional antigen-presenting cells makes IL-4, providing
no candidates to deliver high concentrations of this
cytokine to responding T cells. Some non-antigen-pre-
senting cells, including mast cells and basophils, can make
IL-4 [18]. Recent studies in which normal CD4+ T cells
were transferred to IL-4-deficient 'knockout' mice indi-
cated that production of IL-4 by cells other than CD4+ T
cells is not required for T2 polarization to occur [19]. A
potentially intriguing source of IL-4 is a unique minor
subset of T cells, the CD4+NK1.1+ cells, which recog-
nize a nonpolymorphic class I molecule (CD-1), the
known expression of which is limited [20,21]. There is
also emerging evidence that correlates the presence of
CD4+NK1.1+ cells with T2 polarization of an immune
response (W.E. Paul, personal communication). The hypo-
thetical pathways here are not clear-cut, however. Mast
cells and basophils are thought to be activated by binding
immunoglobulin E (IgE), which is produced late in some
antibody responses, and thus their production of IL-4
could potentially play a role only late in the response -
and it is not yet clear what conditions would preferen-
tially activate the CD4+NKi.1 + cells to make IL-4.
Another possible source of cytokines is, of course, T cells
themselves. An ongoing local response could potentially
produce enough interferon y or IL-4 to lead to polariza-
tion of a newly developing response. This is a rather unat-
tractive concept, because in this case the polarization is not
linked to the pathogen. An alternative possibility is that
as they respond, differentiating T cells produce sufficient
IL-4 (or interferon y) to be self-polarizing. Recent exper-
iments, in which T cells that up-regulate the IL-4 pro-
moter can be targeted to die, support a model in which
CD4+ T cells produce IL-4 as they differentiate to effec-
tors, regardless of their future polarization [22]. Recently,
we have reported that naive T cells can synthesize IL-4
within 48 hours of initial activation, provided that they
recognize antigen repeatedly [23]. In this light, it is inter-
esting that the effects of IL-4 are often dominant over
those of interferon y, suggesting that production of TO
cytokines would favor T2 polarization [10]. This paradigm
also suggests a mechanism whereby high doses of antigen
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in vivo [12], providing repeated stimulation, or high-affin-
ity interaction of peptide with class II MHC molecules
[13], might promote predominant T2 responses. The
potential sources of cytokines are summarized in Table I.
An additional consideration is that polarization may not
always, or even usually, be initiated at the inception of the
immune response. As reflected in Figure 1, uncommitted
TO effector cells can be driven to become polarized at the
effector stage [24], and we have shown that even resting
memory cells can undergo polarization ([25] and L.M.
Bradley, M. Croft and S.L.S., unpublished observations)
at a time during which cytokines produced by all of the
candidate cell types discussed above might be available.
Moreover, there is increasingly evidence to suggest that
effectors can produce somewhat different patterns of
cytokines in response to different signals, providing the
possibility for autocrine polarization influenced by the
antigen-presenting cell type at the effector stage. For
instance, we find that antigen-presenting cells providing
costimulation through the surface molecule B7.1 induce
both IL-2, IL-4 and the production of interferon y from
a population of effectors, whereas antigen-presenting cells
without B7.1 induce IL-4 only (C. Dubey, M. Croft and
S.L.S., unpublished observations).
Another possibility is that factors affecting polarization
might intervene through the selective expansion or death
of effector populations committed to producing T1 or T2
cytokines. For instance, it appears that T1 CD4+ effectors
are highly susceptible to rapid, antigen-induced apoptosis,
whereas T2 CD4+ effectors are more resistant (X. Zhang
and S.L.S., unpublished observations). This raises the pos-
sibility that the T2 subset will become predominant
under conditions of chronic antigen stimulation, simply
because a higher fraction of T2 cells survive. The chal-
lenge of the coming years will be- to determine which of
these potential sources of cytokines and mechanisms of
polarization are relevant in vivo.
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